Therapeutic evaluation of homeopathic treatment for canine oral papillomatosis by Raj, P. Albert Arockia et al.
Veterinary World, EISSN: 2231-0916 206




Therapeutic evaluation of homeopathic treatment for canine oral 
papillomatosis
P. Albert Arockia Raj1, Selvaraj Pavulraj2, M. Asok Kumar3, S. Sangeetha4, R. Shanmugapriya4 and S. Sabithabanu4
1. Veterinary Dispensary, Department of Animal Husbandry, Radhapuram, Villupuram, Tamil Nadu, India; 2. Institute
of Virology, Center for Infectious Medicine, Freie University of Berlin, Robert-von-Ostertag-Street 7-13, Berlin - 14163, 
Germany ; 3. Division of Pathology, Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India; 4. Madras 
Veterinary College, Chennai, Tamil Nadu, India.
Corresponding author: P. Albert Arockia Raj, e-mail: palbert1982@gmail.com
Co-authors: SP: pavulraj.vet@gmail.com, MAK: drasokvet@gmail.com, SS: sangeethavet15@gmail.com,  
RS: rajaramshanmugam04@gmail.com, SSab: dr.sabithabanu@gmail.com
Received: 04-08-2019, Accepted: 23-12-2019, Published online: 31-01-2020
doi: www.doi.org/10.14202/vetworld.2020.206-213 How to cite this article: Raj PAA, Pavulraj S, Kumar MA, Sangeetha S, 
Shamugapriya R, Sabithabanu S (2020) Therapeutic evaluation of homeopathic treatment for canine oral papillomatosis, 
Veterinary World, 13(1): 206-213.
Abstract
Aim: A study was conducted to evaluate the ameliorative potential of homeopathic drugs in combination (Sulfur 30C, Thuja 
30C, Graphites 30C, and Psorinum 30C) in 16 dogs affected with oral papillomatosis which was not undergone any previous 
treatment.
Materials and Methods: Dogs affected with oral papillomatosis, which have not undergone any initial treatment and fed 
with a regular diet. Dogs (total=16) were randomly divided into two groups, namely, homeopathic treatment group (n=8) 
and placebo control group (n=8). Random number table was used for allocation. Homeopathic combination of drugs and 
placebo drug (distilled water) was administered orally twice daily for 15 days. Clinical evaluation in both groups of dogs 
was performed by the same investigator throughout the period of study (12 months). Dogs were clinically scored for oral 
lesions on days 0, 5, 7, 10, 15, 20, 25, 30, 45, 60, 90, 120, and 150 after initiation of treatment.
Results: The homeopathic treatment group showed early recovery with a significant reduction in oral lesions reflected by 
clinical score (p<0.001) in comparison to placebo-treated group. Oral papillomatous lesions regressed in the homeopathic 
group between 7 and 15 days, whereas regression of papilloma in the placebo group occurred between 90 and 150 days. 
The homeopathic treated group was observed for 12 months post-treatment period and no recurrence of oral papilloma was 
observed.
Conclusion: The current study proves that the combination of homeopathy drugs aids in fastening the regression of canine 
oral papilloma and proved to be safe and cost-effective.
Keywords: Graphites, homeopathy, oral papillomatosis, Psorinum, Sulfur, Thuja.
Introduction
Papilloma is a benign, exophytic, neoplastic 
proliferation of squamous epithelium caused by 
infection with papillomavirus; a non-enveloped 
double-stranded DNA virus which has a tropism 
for mucous membrane and skin [1]. Papillomavirus 
infections were associated with the various neoplastic, 
hyperplastic, and dysplastic condition in human and 
animals [2]. Canine oral papillomatosis (COP) is the 
most common, self-limiting neoplastic disease of dogs 
caused by canine oral papillomavirus (COPV). Dogs 
of <4 years old are commonly affected and there is no 
difference in the prevalence of COP among different 
breeds of dogs with no gender predisposition [3]. COP 
is characterized by high morbidity and low mortality 
with good prognosis, and animal stays immune for the 
rest of life [4]. Older dogs, puppies, and immunocom-
promised dogs are more susceptible to contracting 
the papillomavirus. COPV affects dog’s oral mucous 
membrane (dogs younger than 2 years of age) and 
older dog’s skin [5-8]. Various therapeutic approaches 
are available for treating COP, such as autoimmune 
therapy, laser therapy, surgical therapy, cryotherapy, 
photodynamic therapy, intravenous injection of vin-
cristine sulfate/taurolidine/immunoregulin, intramus-
cular injections of anthiomaline (lithium antimony 
thiomalate), oral administration of azithromycin, and 
topical application of fluorouracil/Thuja [9].
Recently, homeopathic treatment approaches 
gaining significant interest among physicians and 
veterinarians. Homeopathy is a system of treatment 
where minute quantities of substances are serially 
diluted and potentiated, which in larger doses might 
produce symptoms similar to those of the ailment being 
treated [10]. Preparation of homeopathic medicines 
includes preparation of mother tinctures and potencies, 
indicated by the letter “C” (Centesimal). Doses of 
homeopathic medicines are not expressed in amount 
as mg and instead they are expressed in potency or C . 
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Potency is the optimum power of medicine or remedy 
which given in minimum dose at specified intervals, 
depending on the nature of the disease and the sus-
ceptibility of the subject would cure the sickness in 
minimum time [11]. It is usually used to refer to the 
degree of dilution that a homeopathic remedy has 
undergone in its manufacturing process. This is indi-
cated by the number and letter listed after the name of 
the remedy. For example, sulfur 30C has undergone 
30 steps of dilution, each step has been a one to one 
hundred dilution (indicated by the letter “C” meaning 
centesimal) [12,13]. Homeopathic drugs are recently 
used in treating conditions such as canine atopic 
dermatitis [14], canine babesiosis [15], idiopathic 
epilepsy in dogs [16], bovine mastitis [17,18], endo-
metritis in dairy cows [19], diarrhea in neonatal pig-
lets [20], and bovine papillomatosis [21] in animals.
With this background, the present study was 
aimed to evaluate the therapeutic effectiveness of 
homeopathic medicines, namely, Sulfur 30C, Thuja 




Necessary approval for the clinical trial was 
obtained from Tamil Nadu Animal Husbandry 
Department (Villupuram), (18/2015). Signed consent 
statement was collected from each dog owner before 
initiation of the clinical trial. 
Source of dogs and obtaining owner consent for 
experimentation
The study was performed at Veterinary 
Dispensary, Radhapuram, Villupuram, India, between 
January 1, 2016, and January 1, 2017. A total of 259 
canine cases were reported during the period, of which 
16 dogs were diagnosed as COP based on lesions in 
the oral cavity. Consent was obtained from respec-
tive animal owners before the dogs were subjected to 
placebo and treatment with homeopathic drugs. The 
details of the dogs under study are listed in Table-1.
Clinical examination
The location, size, and shape of the papillomato-
sis lesions were recorded and photographed.
Drugs
Four homeopathy drugs, namely, Graphites, 
Psorinum, Sulfur, and Thuja with 30C potency 
(Schwabe International GmbH, Germany) were pro-
cured from a local dealer in India (Mashan Distributors, 
Chennai).
In veterinary practice, homeopathic preparations 
of Sulfur, Graphites, Psorinum, and Thuja were used 
in the form of 30C potency for treating dermatological 
cases [22]. Thus, all the four homeopathy drugs were 
used in the strength of 30C potency and given orally at 
2 drops\5 kg body weight (BW) (Graphites 30+Sulfur 
30+Psorinum 30+Thuja 30) each. Distilled water was 
used as a placebo drug for the corresponding group.
Study design
A prospective, parallel, randomized, double- 
blinded, and placebo-controlled study design was 
planned for this experiment by the investigator as 
described previously [23]. Briefly, all 16 dogs were 
randomly divided into two groups with eight dogs in 
Group A (placebo control group) and eight dogs each 
in Group B (homeopathic drugs treatment group). 
Random allocation was done using tables of random 
numbers. The person who allocated the dogs into two 
groups was blinded from the knowledge of treatment 
to avoid allocation bias in the assignment of treat-
ments. The person involved in sequence generation 
by randomization was not allowed for the allocation 
of dogs into treatment groups. The allocations of dogs 
into treatment and placebo groups were kept blind to 
the knowledge of both animal owners and investiga-
tors. The placebo and combination of homeopathic 
drugs were filled in similar bottles and consecutively 
numbered for each dog according to the randomization 
schedule. All the dogs in Group A were administered 
with distilled water orally at 8 drops\5 kg BW. All the 
Group B dogs were treated with homeopathic drugs 
in combination (Sulfur 30, Thuja 30, Psorinum 30, 
and Graphites 30) orally. Each homeopathy drug was 
given at the rate of 2 drops\5 kg BW. Homeopathic 
drugs in combination and placebo were given twice 
daily for 15 days in 12 h interval. The final dose with 
homeopathic drug combination used for this current 
experiment was arrived based on the pilot study (data 
not shown). Vaccinations or any other supplementary 
treatment were not permitted during the study period. 
All the dogs were fed with a regular diet. The main 
inclusion criterion for the selection of dogs for the 
experiment was the dogs which have not undergone 
any initial treatment to find the potential effectiveness 
of the homeopathic drug in treating COP.
Table 1: Details of dogs that were used in the 
experimental study.
S. No. Breed Sex Age in 
months
Group
1. Nondescript Male 9 Group A
2. Nondescript Male 5
3 Labrador Female 8
4. Nondescript Female 5
5. German shepherd Male 6
6. Nondescript Male 5
7. Doberman Male 9
8. Nondescript Male 3
9. Labrador Female 9 Group B
10. Nondescript Male 5
11. German shepherd Female 4
12. Nondescript Female 7
13. Nondescript Male 6
14. Labrador Male 6
15. Nondescript Female 7
16. Pomeranian Female 8
Group A=Control group treated with placebo, 
Group B=Homeopathic group treated with a combination 
of Sulfur 30+Graphites 30+Thuja 30+Psorinum 30
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Clinical scoring
The clinical scoring of papilloma was performed 
as described previously [23]. Evaluation of the clini-
cal signs and progression of treatment were compared 
in both groups of dogs. Dogs were clinically scored 
by examining the oral lesions on 0, 5, 7, 10, 15, 20, 
25, 30, 45, 60, 90, 120, and 150 days post-treatment. 
The investigator is blinded to the type of treatment 
given. The dogs were clinically scored for severity 
and regression of papilloma lesions which ranged 
from scores 0 to 3 (absent-0, mild-1, moderate-2, and 
severe-3), +1 for <10 number of papillomas, and +2 
>10 number of papillomas. Dogs in both groups were 
examined for the presence of any adverse effect of the 
treatment. All the dogs were observed for 12 months 
for any recurrence of papilloma.
Sample collection for histological and molecular 
analysis
Physical examination, complete blood count, 
and serum biochemistry were performed for all 
the dogs at different time points. Biopsy samples 
were taken from papillomatous lesions on 0th and 
7th days post-treatment from dogs under sedation 
(Atropine at 0.04 mg/kg BW, Xylazine at 1 mg/kg 
BW). Biopsy specimens were collected from the buccal 
region and were samples fixed in 10% neutral buffered 
formalin, and tissues were processed by routine paraf-
fin-embedding technique. Briefly, 4-5 µm thick sections 
were cut and stained by routine hematoxylin and eosin 
for detailed histopathological studies. In addition, piece 
of biopsy tissues collected from each animal was stored 
at −70°C for nucleic acid-based molecular studies.
DNA isolation and polymerase chain reaction (PCR)
Biopsy tissue samples for viral DNA extraction 
were collected on the 0th day for PCR confirmation 
of canine papillomavirus infection. Collected papil-
lomatous tissue samples were homogenized with the 
help of tissue homogenizer and viral DNA extracted 
using QIA amp mini kit (Qiagen, Germany) as per 
manufacturer’s instructions. Isolated DNA samples 
were stored at −70°C until further use. Primers were 
designed based on the reported sequence of canine 
papillomavirus 1 (Accession number: L22695.1) tar-
geting L1 open reading frame. PCR was performed on 
isolated DNA samples using a set of primer sequence, 
forward primer: 5’-ctgaaaaagaaagacttgtttg-3’ and 
reverse primer: 5’-attgccccatgcaatcccatta-3’. Viral 
DNA samples were amplified using PCR in a final 
volume of 25 µl containing 5 µl 5× Phusion® HF buf-
fer, 0.5 µl of 10 mM dNTPs, 1.25 µl of 10 mM for-
ward primer, 1.25 µl of 10 mM reverse primer, 0.25 
µl Phusion® DNA polymerase, 5 µl of isolated DNA 
sample, and 11.75 µl of nuclease-free water. Thermo 
cycling was performed in Eppendorf® Thermo Cycler 
(6331 Nexus gradient Mastercycler Thermal Cycler, 
Germany) with the following cycling condition: One 
cycle at 98°C for 30 s, then 35 cycles of 10 s at 98°C, 
30 s at 55°C, and 30 s at 72°C and final extension 
at 72°C for 10 min. Five microliters of PCR product 
obtained after amplification was run on 1.5% agarose 
gel in 0.5× Tris-acetate-EDTA buffer containing 1 μl 
of 1% ethidium bromide at 100 volts for 1 h along with 
1 kb plus marker (Thermo Fisher Scientific™). Results 
were documented using UVP-GDS-2000® gel docu-
mentation system. Visualization of a band of 707 base 
pair (bp) size amplified product was the confirmation 
for the presence of canine papillomavirus nucleic acid 
in the tissue sample.
Statistical analysis
Mann–Whitney U-test was used to analyze the 
difference in the clinical score observed between the 
two groups. Wilcoxon test was used to compare the 
clinical success rate of each treatment group with 




Clinical examination of dogs revealed almost 
normal physiological activity (body temperature, heart 
rate, respiration rate, and conjunctival mucous mem-
brane) with the exception of a few animals showed 
mild-to-moderate anorexia because of oral papilloma-
tous lesions. Results of the complete blood count and 
serum chemistry of all dogs were within the normal 
range (data not shown).
Clinical examination
Examination of the oral cavity revealed numer-
ous papillomatous growths protruding from the sur-
face of oral mucous membranes of infected dogs. 
Papilloma noticed as small smooth papules (as few 
millimeters in diameter) to cauliflower-like growth/
warts of varied sizes (up to 2-3 cm in diameter). Warts 
were grayish-white, pink, and black in color due to 
pigmentation. Grossly, lesions were characterized by 
hard verrucose, proliferative, and hyperkeratotic usu-
ally variable sized, multiple, sessile, and also single 
and cluster (Figure-1). The papilloma had smooth and 
rough, jagged, and crumbling surfaces which can be 
Figure-1: In Group B, variable-sized proliferative 
papillomas in the oral cavity, lips and mucocutaneous 
junction on day 0 of treatment.
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removed but causes bleeding. Papillomatous lesions 
had narrow base with a wide projection on the muco-
sal surface. Cut sections revealed multiple fingers like 
projections. A tentative diagnosis of COP was made 
based on clinical examination. It should be noted that 
there was no associated dermatological abnormality in 
all the dogs except oral papilloma lesions.
In Group A, none of the dogs treated with pla-
cebo showed regression of oral lesion on 7 days of 
post-treatment. In Group B, treatment with homeo-
pathic drug combination resulted in complete regres-
sion of oral lesion in 7 days (4 of 8 dogs). On the 
10th day of post-treatment, none of the dogs in Group A 
showed regression but in Group B, three more dogs 
showed complete regression. On the 15th day of 
post-treatment, still, none of the dogs in Group A 
showed regression of oral lesion but in Group B, the 
remaining one dog showed complete regression. On 
contrary to the treatment group, the placebo treatment 
group showed regression from the 90th day onward. 
Shortly, three dogs showed complete regression of 
papilloma around 90th day and two dogs on 120th day 
after post-placebo treatment. Remaining three dogs in 
the placebo group showed regression around 150th day.
Histopathological examination
Histopathological examination of the papillo-
matous lesion before treatment was characterized by 
severe hyperplasia of stratum corneum layer of strat-
ified squamous epithelium, multiple rete pegs for-
mation with central fibrous core (Figures-2 and 3). 
Moderate to severe infiltrations of keratohyalin gran-
ules were observed in the cytoplasm of proliferating 
epithelial cells. The presence of intranuclear inclusions 
in the keratinocytes was noticed in a few sections. 
Other associated findings noticed were parakeratosis 
and eosinophilic cytoplasmic inclusions (koilocytes). 
Tissue sections of dogs from 5th day of homeopathic 
treatment revealed reduction in hyperplastic changes, 
development of uniform cells without anaplastic 
changes, neovascularization in between fibrous stroma 
of core, moderate to severe diffuse infiltration of the 
mononuclear cells in the connective tissue stroma, 
loss of keratin layer as a whole, and a focal area of 
keratinization with nucleus in stratum corneum were 
noticed suggesting regeneration (Figure-4).
PCR
PCR analysis revealed the association of canine 
papillomavirus in all dogs with papillomatous oral 
lesions. PCR amplification of canine papillomavirus 
DNA isolated from papillomatous tissue from dogs 
showed an amplicon size of 707 bp (Figure-5).
Clinical score
On day 0, the clinical scores of both groups were 
the same. The mean clinical score of dogs belong-
ing to Group A and Group B is presented in Table-2 
and Figure-6. In Group A, lesion score for papilloma 
remained the same (4.375) on 5, 7, 10, and 15 days 
post-treatment (maximum score is 5). In contrast, 
lesion score in Group B was only 2.25, 0.75, and 
0.25 on 5, 7, and 10 days post-treatment. Further, no 
lesion observed on day 15 in Group B. Homeopathic 
Figure-2: In Group B, at day 0 of treatment, hyperplasia of 
stratum corneum with severe infiltrations of keratohyaline 
granules in the cytoplasm of proliferating epithelial cells. 
Hematoxylin and eosin 400×.
Figure-4: In group B, 5th day of homeopathic treatment 
showed reduced hyperplasia, neovascularization, 
parakeratosis with severe infiltration of mononuclear cells 
in connective tissue stroma. Hematoxylin and eosin 100×.
Figure-3: In Group B, hyperplasia of stratum corneum of 
stratified squamous epithelium with the central fibrous core 
on day 0 of treatment. Hematoxylin and eosin 100×.
Veterinary World, EISSN: 2231-0916 210
Available at www.veterinaryworld.org/Vol.13/January-2020/31.pdf
treatment (Group B) showed early regression of 
papilloma lesion on day 5 (Figure-7) with significantly 
lower clinical score than placebo group (p<0.05) and 
on days 10, 15, 20, 25, 30, 45, and 60, (p<0.001). In 
contrast, Group A showed regression of papilloma 
with a reduction of clinical score from the 90th day 
(p<0.05) in score compared to baseline and complete 
regression by the 150th day. The homeopathic drug 
combination-treated Group (B) showed significant 
improvement throughout the observation period from 
days 5 (p<0.05) to 150 (p<0.001) in scores compared 
to baseline.
Discussion
Despite autoregression, treating oral papilloma 
cases are very crucial because of the physical diffi-
culty the animal faces while taking food, restriction 
from social interaction with other dogs, anorexia, 
drooling, halitosis, bleeding, secondary bacterial 
infections, and purulent discharge near papillomas [4]. 
Various therapeutic regimes were used to alleviate 
COP. External application of apple cider vinegar, pod 
wart, and petroleum jelly [9] Thuja occidentalis [24], 
imiquimod, and 5-fluorouracil [8]; oral administration 
of levamisole [3], cimetidine [25], interferon alfa [7], 
human recombinant interferon-α 2a [26], T. occidenta-
lis [27], acyclovir [28], etretinate [7], and azithromy-
cin [23]; subcutaneous injection of tarantula cubenis 
extract [29], feline recombinant interferon-ω [30], 
autogenous vaccine [31], and T. occidentalis [32]; 
intramuscular injection of lithium antimony thioma-
late [9]; intramuscular injection of Propionibacterium 
acnes [33]; intralesional administration of interferon 
alfa [7]; and intravenous injection of vincristine sul-
fate and immunoregulin [31], and taurolidine [3] were 
reported. Injectable interferon directly stimulates the 
immune system thereby helps to resolve warts. Non 
or semi-invasive approaches such as surgical excision, 
debulking of exophytic lesion with electro or radiosur-
gery or by sharp resection, electrocautery, cryotherapy, 
Figure-5: Polymerase chain reaction (PCR) amplification 
of canine papillomavirus DNA isolated from papillomatous 
tissue from dogs. PCR product of 707 base pair product 
confirms positive amplification. M – 1 kb plus marker, 
L1 - L7: PCR product for tissue samples. L1: Nontemplate 
negative control; L2-L7: Oral papilloma samples.
Figure-6: Comparison of clinical scores between Group A 
(control) and Group B (homeopathic group) during 
150 days of the experiment.
Table-2: Clinical score received from the dogs affected 
with oral papilloma in Group A (control group) and 
Group B (homeopathic treatment group) during 150 days 
of observation (mean±standard deviation).







0 4.375±0.517 4.5±0.534 0.5
5 4.375±0.517 2.25±1.164 0.007
7 4.375±0.517 0.75±1.035 <0.001
10 4.375±0.517 0.25±0.707 <0.001
15 4.375±0.517 0 <0.001
20 4.375±0.517 0 <0.001
25 4±0.925 0 <0.001
30 4±0.925 0 <0.001
45 3.375±0.916 0 <0.001
60 2.125±1.125 0 <0.001
90 1.125±1.125 0 0.013
120 0.5±0.755 0 0.100
150 0 0 1.000
aSignificance of difference between control and treatment 
group. p<0.05 is considered as statistically significant
Figure-7: Regression of papilloma lesions on the 5th of 
homeopathic drug treatment.
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crushing of warts to stimulate immunity [9], crushing 
laser or cryosurgery [8], photodynamic therapy [34], 
and spontaneous regression and autoimmune ther-
apy [35] were also reported. COP can be treated with 
combination of inactivated autogenous vaccine, che-
motherapy, and application of T. occidentalis in a 
dog [36]. A recombinant COPV vaccine shows prom-
ising results in COP cases which were not responded 
to treatment [1].
Treatment such as surgical removal and vac-
cination may increase the size of residual warts and 
prolong the course of the disease. Surgical removal 
becomes difficult when the extend of papilloma lesion 
is more [32]. The relationship between clinical reso-
lution and surgical intervention is difficult to deter-
mine due to the frequent spontaneous regression of 
this papilloma. Treatment is not guaranteed through 
surgical removal of warts as the papillomavirus is 
still in the dog’s body leading to latent infection and 
increased recurrence [37]. Anesthesia is required for 
surgical removal of warts which make the surgical 
way of treating papilloma riskier in addition to spe-
cial care and high cost. Laser and cryotherapy are used 
in the ablation of papilloma but multiple treatments 
are generally needed [38]. Autogenous vaccine and 
immune modulation drugs such as levamisole and 
thiabendazole are used but proof for their efficiency 
is lacking [7]. Systemic or local chemotherapy drugs 
such as vincristine, vinblastine, cyclophosphamide, 
methotrexate, chlorambucil, and doxorobucin lead to 
inefficient or controversial results in the majority of 
papilloma cases, with longer duration of the treatment 
period and varying degrees of success [3,34].
Homeopathy is an alternative therapy available at 
affordable prices and becoming increasingly popular 
in human medicine in developing countries that have 
negligible adverse effect with the use [39]. Agnihotri 
et al. [9] reported that treating canine oral papil-
loma with Thuja alone for 2 months was not effec-
tive. Combinations of Sulfur 30+Thuja 30+Graphites 
30+Psorinum 30 have been selected for the treatment 
in our experiment. These homeopathy drugs have been 
used in human medicine for long. None of the homeo-
pathic drugs used in this experiment have been proven 
to cause any side effect. It has been already proved that 
Thuja (T. occidentalis) has immunomodulatory and 
antiviral properties which cause B and T lymphocyte 
proliferation and differentiation into CD4+ cells and 
induces production of interleukin (IL)-2, IL-1, IL-6, 
tumor necrosis factor-α, and interferon-γ production 
in vitro and in vivo [40]. Sulfur 30 promotes healthy 
skin condition which heals damaged skin, Graphites 30 
is a powerful anti-psoric and commonly used against 
eruptions in the skin and mucosal surfaces in humans 
and Psorinum 30 also has anti-psoric activity [41]. 
Sulfur was used to treat pruritus associated with atopic 
dermatitis in dogs [14]. Graphites were used to treat 
hypertrophic burn scars successfully in humans [42] 
and canine demodicosis [43]. Combination of Sulfur, 
Psorinum, and Graphites with other homeopathic 
drugs was used in dogs for treating various skin con-
ditions such as seborrhea, pruritus, allergic dermati-
tis, and Hot Dog Syndrome [44]. Sulfur, Psorinum, 
and Graphite in combination are used to treat canine 
mange [45]. Madrewar and Glencross [22] have stated 
the use of different combinations of homeopathy drugs 
against all kinds of dermatitis, ringworm, wet or dry 
eczema and to remove warts of all types on any part 
of the animal body. The combination of homeopathic 
drugs (Sulfur 30+Thuja 30+Graphites 30+Psorinum 
30) was found to be very effective in the treatment of 
COP; as a result, complete regression of papilloma 
lesions observed between 7 and 15 days after initiation 
of treatment. Further, no adverse effect was observed 
during the course and after the treatment. No recur-
rence of papilloma was observed during the follow-up 
period of 12 months in all treated dogs. It proves that 
these combinations Sulfur 30+Thuja 30+Graphites 
30+Psorinum 30 could be used as a potential non-inva-
sive method for the successful treatment of COP which 
would be alternate to surgical removal or using toxic 
drugs like vincristine.
Conclusion
The result of this investigation proves that the 
combination of homeopathic drugs (Sulfur 30+Thuja 
30+Graphites 30+Psorinum 30) offers an attractive, 
non-invasive and most economical way of treating 
COP. A combination of homeopathic drugs is a novel 
approach for treating canine oral papilloma and further 
studies are needed to elucidate the use of homeopathic 
combination as a veterinary oncological therapeu-
tics and to explore the mechanism of action of these 
homeopathic drugs in ameliorating oral papilloma.
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